Anne R. McCall
University of Chicago
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Anne R. McCall.
Practical radiation oncology | 2017
Lauren C. Das; Daniel W. Golden; Eugenia Perevalova; Anthony C. Wong; Kimberly De Nardo; Christopher Stepaniak; Daniel S. Joyce; B McCabe; Yasmin Hasan; Steven J. Chmura; Anne R. McCall
PURPOSE The purpose of this study was to prospectively evaluate the use of daily 2-mm bolus in patients undergoing postmastectomy radiation without reconstruction using optically stimulated luminescence dosimetry and weekly assessment of skin toxicity. METHODS AND MATERIALS We prospectively collected data from the first 49 women treated with a daily 2-mm Superflab bolus during their postmastectomy radiation therapy from 2013 to 2016 at The University of Chicago Comprehensive Cancer Center at Silver Cross. Within the first 3 days of starting radiation therapy, we measured the surface dose in vivo at 5 anatomical locations under the 2-mm bolus on the chest wall. We assessed weekly the acute skin toxicity during radiation using the National Cancer Institute Common Toxicity Criteria. Patients with reconstruction before radiation therapy were excluded. RESULTS Forty-nine women with a mean age of 54.3 years were treated with daily 2-mm bolus to the chest wall following mastectomy. Median follow-up was 32.7 weeks. The mean percentages of prescribed dose (standard deviation) for the median, central, lateral, superior, and inferior optically stimulated luminescence dosimeters were 100.1% (5.6%), 108.1% (6.7%), 98.1% (6.5%), 102.6% (8.9%), and 106.3% (6.6%), respectively. The majority (71.4%) of women experienced a maximum acute National Cancer Institute Common Toxicity Criteria skin toxicity score of 2, with only 12.2% experiencing a score of 3. There were no grade 4 toxicities. There were no local recurrences during our follow-up period. CONCLUSIONS A daily 2-mm bolus is a feasible regimen for chest wall bolus during postmastectomy radiation therapy with acceptable dose buildup and skin toxicity.
International Journal of Radiation Oncology Biology Physics | 1994
Elyse Erlich; Ronald K. Potkul; Anne R. McCall; Scott Walter; Andrew T. Vaughan
Materials and Methods: The two human ceil lines C-33A (HTB 31) and MS751 (HTB 34) were exposed to 1 x10”’ M to 1 x IO” M Pactitaxel for 24 hours. At this time the drug was washed off the cells and sample exposed to graded doses of Cs-137 radiation from O-4 Gy. These samples were then incubated for approximately 7-10 days to allOW colony formation, Separate samples were also followed for at least 6 days with daily sampling for cell cycle analysis.
Gynecologic Oncology | 1993
James R. Dolan; Anne R. McCall; Saro Gooneratne; Scott Walter; David M. Lansky
Journal of Clinical Oncology | 2018
Subha Perni; Andrew J. Einstein; D.P. Horowitz; Michael Rooney; Daniel W. Golden; Anne R. McCall; Reshma Jagsi
Journal of Clinical Oncology | 2018
Yasmin Hasan; Michael T. Spiotto; Larissa V. Furtado; Nita Karnik Lee; R. Brooks; Anne R. McCall; Daniel W. Golden; Shruti Jolly; Gini F. Fleming; Matthew P. Morrow; Jeffrey M. Skolnik; Mark T. Esser; Rakesh Kumar; Ralph R. Weichselbaum
International Journal of Radiation Oncology Biology Physics | 2014
L. Herman; Anthony C. Wong; E. Perevalova; Christopher Stepaniak; Daniel W. Golden; Yasmin Hasan; S.J. Chmura; Anne R. McCall
International Journal of Radiation Oncology Biology Physics | 2013
A.A. Solanki; M.H. LeMieux; A.A. Chaudhary; Anne R. McCall; S.J. Chmura
International Journal of Radiation Oncology Biology Physics | 2013
A.A. Solanki; M.H. LeMieux; A.A. Chaudhary; Anne R. McCall; S.J. Chmura
International Journal of Radiation Oncology Biology Physics | 1998
Matthew J. Krasin; Anne R. McCall; Stephanie A. King; Bahman Emami
International Journal of Radiation Oncology Biology Physics | 1996
B.S. Editha A. Krueger; James R. Dolan; Ronald K. Potkul; Susan G. Fisher; Anne R. McCall